.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Teva
Healthtrust
QuintilesIMS
Julphar
Deloitte
Fuji
Moodys
Mallinckrodt
AstraZeneca

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022370

« Back to Dashboard
NDA 022370 describes CONZIP, which is a drug marketed by Cipher Pharms Inc and is included in one NDA. It is available from thirteen suppliers. There is one patent protecting this drug. Additional details are available on the CONZIP profile page.

The generic ingredient in CONZIP is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.

Summary for NDA: 022370

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 022370

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 022370

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CONZIP
tramadol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL 022370 NDA AUTHORIZED GENERIC Trigen Laboratories, LLC 13811-689 13811-689-30 30 CAPSULE in 1 BOTTLE, PLASTIC (13811-689-30)
CONZIP
tramadol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL 022370 NDA AUTHORIZED GENERIC Trigen Laboratories, LLC 13811-690 13811-690-30 30 CAPSULE in 1 BOTTLE, PLASTIC (13811-690-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength100MG
Approval Date:May 7, 2010TE:RLD:Yes
Patent:7,858,118Patent Expiration:Apr 11, 2022Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE OF TRAMADOL FOR THE MANAGEMENT OF MODERATE TO MODERATELY SEVERE CHRONIC PAIN

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength200MG
Approval Date:May 7, 2010TE:RLD:Yes
Patent:7,858,118Patent Expiration:Apr 11, 2022Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE OF TRAMADOL FOR THE MANAGEMENT OF MODERATE TO MODERATELY SEVERE CHRONIC PAIN

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength300MG
Approval Date:May 7, 2010TE:RLD:Yes
Patent:7,858,118Patent Expiration:Apr 11, 2022Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE OF TRAMADOL FOR THE MANAGEMENT OF MODERATE TO MODERATELY SEVERE CHRONIC PAIN


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
UBS
Merck
McKesson
Fuji
Julphar
Express Scripts
McKinsey
Citi
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot